A genomic and proteomic examination of 232 cases of renal clear cell carcinoma revealed that NNMT contributes to the immune response of renal cell carcinoma via one-carbon metabolism and is a potential therapeutic target (Qu et al., 2022). Here, NNMT is linked to hereditary clear cell renal cell carcinoma.